Next Article in Journal / Special Issue
NORE1A Regulates MDM2 Via β-TrCP
Previous Article in Journal
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
Previous Article in Special Issue
Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
Open AccessArticle

Proteomics Analysis Reveals Novel RASSF2 Interaction Partners

Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA
Department of Medicine, James Graham Brown Cancer Center, Molecular Targets Program, University of Louisville, Louisville, KY 40202, USA
Author to whom correspondence should be addressed.
Academic Editor: Reinhard Dammann
Cancers 2016, 8(3), 37;
Received: 14 January 2016 / Revised: 18 February 2016 / Accepted: 9 March 2016 / Published: 16 March 2016
(This article belongs to the Special Issue RASSF Signalling in Cancer)
RASSF2 is a tumor suppressor that shares homology with other Ras-association domain (RASSF) family members. It is a powerful pro-apoptotic K-Ras effector that is frequently inactivated in many human tumors. The exact mechanism by which RASSF2 functions is not clearly defined, but it likely acts as a scaffolding protein, modulating the activity of other pro-apoptotic effectors, thereby regulating and integrating tumor suppressor pathways. However, only a limited number of RASSF2 interacting partners have been identified to date. We used a proteomics based approach to identify additional RASSF2 interactions, and thereby gain a better insight into the mechanism of action of RASSF2. We identified several proteins, including C1QBP, Vimentin, Protein phosphatase 1G and Ribonuclease inhibitor that function in diverse biological processes, including protein post-translational modifications, epithelial-mesenchymal transition, cell migration and redox homeostasis, which have not previously been reported to interact with RASSF2. We independently validated two of these novel interactions, C1QBP and Vimentin and found that the interaction with C1QBP was enhanced by K-Ras whereas, interestingly, the Vimentin interaction was reduced by K-Ras. Additionally, RASSF2/K-Ras regulated the acetylation of Vimentin. Our data thus reveal novel mechanisms by which RASSF2 may exert its functions, several of which may be Ras-regulated. View Full-Text
Keywords: RASSF2; Vimentin; K-Ras; acetylation; SIRT1 RASSF2; Vimentin; K-Ras; acetylation; SIRT1
Show Figures

Figure 1

MDPI and ACS Style

Barnoud, T.; Wilkey, D.W.; Merchant, M.L.; Clark, J.A.; Donninger, H. Proteomics Analysis Reveals Novel RASSF2 Interaction Partners. Cancers 2016, 8, 37.

AMA Style

Barnoud T, Wilkey DW, Merchant ML, Clark JA, Donninger H. Proteomics Analysis Reveals Novel RASSF2 Interaction Partners. Cancers. 2016; 8(3):37.

Chicago/Turabian Style

Barnoud, Thibaut; Wilkey, Daniel W.; Merchant, Michael L.; Clark, Jennifer A.; Donninger, Howard. 2016. "Proteomics Analysis Reveals Novel RASSF2 Interaction Partners" Cancers 8, no. 3: 37.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop